AUTL financials
Autolus Therapeutics (AUTL) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
- AUTL revenue was $75.39M in fiscal 2025, net income -$287.53M.
AUTL income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $75.39M | -$20.98M | -$270.54M | -$287.53M | -1.08 |
| 2024 | $10.12M | -$1.27M | -$241.43M | -$220.66M | -0.86 |
| 2023 | $1.70M | $1.70M | -$179.70M | -$208.38M | -1.20 |
| 2022 | – | – | -$143.41M | -$148.84M | -1.57 |
| 2021 | – | – | -$141.05M | -$142.10M | -1.97 |